BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Stem cell
,
Pharmacogenetics
,
Doxorubicin
,
rs2230926
,
GATA1
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
KALRN;jsessionid=851C9E7D347AA3D49E84C243D61FDCA6
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Loading...
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
BubR1 and cyclin B1 immunoexpression in pleomorphic adenoma and polymorphous adenocarcinoma of minor…
Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia.
Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and upd…
Cyclin B1;1 activity is observed in lateral roots but not in the primary root during lethal salinity…
Cell cycle-dependent binding between Cyclin B1 and Cdk1 revealed by time-resolved fluorescence corre…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for KALRN;jsessionid=851C9E7D347AA3D49E84C243D61FDCA6
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ